Deals agreed with Janssen and Novavax for another 90 million doses

Company will manufacture over 25% more doses than previously planned

Clinical trial programme resumes after safety concerns

Companies will jointly validate novel IBD targets

On heels of U.S. pact, Johnson & Johnson strikes a double-size COVID vaccine deal with Europe esagonowsky Thu, […]

Updated Date: Thu, 06 Aug 2020 00:00:00 EDT

Updated Date: Thu, 06 Aug 2020 00:00:00 EDT

Updated Date: Thu, 06 Aug 2020 00:00:00 EDT

A multiple sclerosis drug may be used to block HIV infection and reduce the latent reservoir, according to […]

Antibiotic resistance is an increasing health problem, but new research suggests it is not only caused by the […]